Copart stock hits 52-week low at 45.49 USD

Copart Inc. (CPRT) recently hit a 52-week low of $45.49, reflecting ongoing market pressures despite strong underlying fundamentals, including a healthy current ratio and 10.21% revenue growth. While Q1 2025 EPS of $0.42 met analyst forecasts, revenue slightly missed expectations at $1.21 billion, impacted by a 2% decline in vehicle sales revenue. Analyst sentiment is mixed, with CFRA upgrading CPRT to Strong Buy with a $70 price target, citing justified valuation, while JPMorgan maintained a Neutral rating and lowered its price target to $55 due to concerns over a decline in U.S. insurance unit volume growth, indicating varied outlooks on the company's future performance drivers.

Analysis

Copart Inc. (CPRT) has reached a 52-week low of $45.49, marking a 12.81% decline over the past twelve months and signaling significant market pressure. This price action contrasts with the company's strong fundamentals, which include a robust current ratio of 8.16x and a balance sheet holding more cash than debt. The company's recent Q1 2025 earnings report presented a mixed picture: earnings per share of $0.42 met analyst forecasts, but revenue of $1.21 billion slightly missed the $1.23 billion consensus. This revenue shortfall was driven by a 2% year-over-year decline in vehicle sales, which was partially offset by a 9% increase in service revenue. Analyst sentiment is notably divergent. CFRA issued a "Strong Buy" rating with a $70 price target, viewing the stock's valuation as justified. Conversely, JPMorgan maintained a "Neutral" rating and lowered its price target to $55 from $60, citing specific concerns about a 1% year-over-year decline in U.S. insurance unit volume growth, excluding catastrophe-related units. This division highlights a central tension between Copart's solid financial health and historical performance versus emerging operational headwinds in key business segments.

Key Decisions for Investors

• Investors should consider the disconnect between the 52-week low share price and the company's strong balance sheet, which may present a value opportunity if operational headwinds prove temporary.
• Monitor U.S. insurance unit volume growth closely, as the 1% year-over-year decline is a key risk factor cited by cautious analysts and could signal a slowdown in a core revenue driver.
• Given the mixed analyst ratings, with price targets ranging from $50 to $70, it is prudent to assess whether the current P/E ratio of 29.76x adequately discounts the near-term growth concerns against the long-term potential.
• Evaluate the company's ability to sustain its 9% service revenue growth, as this segment is currently compensating for the weakness in vehicle sales and is critical to meeting overall performance expectations.